Pfizer Buys Arena For $6.7bn In Bid To Diversify In Inflammation & Immunology

S1P Asset Will Add To JAK-Heavy Pipeline

 
• By Jessica Merrill
Wallet
Pfizer is ready to spend on deals • Source: Alamy

More from Deals

More from Business